***Please view using updated link below*** October 5, 2009 We are pleased to announce that WRAL-TV (CBS affiliate) in Raleigh, North Carolina recently aired a piece on EDAP's ongoing clinical trial of Ablatherm High-Intensity Focused Ultrasound (HIFU) as a robotized, non-invasive treatment in
LYON, France, Sep 23, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS S.A. (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the launch of an intensified communication and education strategy in France, aimed at increasing physician and patient awareness of
LYON, France, Sep 10, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS S.A. (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the expansion of Ablatherm-HIFU into new territories as part of the Company's global growth strategy: * The Taiwan Department of Health
Second Quarter 2009 Highlights: * Year-over-year comparisons, Sep 1, 2009 (GlobeNewswire via COMTEX News Network) -- Total revenue of EUR 6.8 million, up 37.0% -- Total HIFU revenue of EUR 2.2 million, up 34.2% -- Ablatherm-HIFU revenue per procedure (RPP) treatments increased 34.9% -- Total
LYON, France, Aug 12, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its second quarter 2009 earnings announcement, which will take place on Tuesday, September 1, 2009, before the opening of
Jul 13, 2009 (GlobeNewswire via COMTEX News Network) -- U.S. Urologist Dr. Douglas Chinn Named Clinical Instructor First Ablatherm-HIFU Patient Treated At Memorial Sloan-Kettering Cancer Center LYON, France, July 13, 2009 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in
LYON, France, Jun 26, 2009 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that Dr. Argil J. Wheelock, MD was appointed to its Board of Directors, effective June 25, 2009. Dr. Wheelock replaces Dr.